Search research articles
Contact Us
Filters
Showing results (31-40 of 278) with videos related to
Page
of 28
Sort By:
Proceedings of the American Thoracic Society
|
October 30, 2010
Bone morphogenetic protein type II receptor mutations causing protein misfolding in heritable pulmonary arterial hypertension
Wei Li, Benjamin J Dunmore, Nicholas W Morrell
Paediatric Respiratory Reviews
|
November 22, 2005
New therapeutic agents for pulmonary vascular disease
Luke S G E Howard, Nicholas W Morrell
Pulmonary Circulation
|
February 16, 2024
Understanding what drives genetic study participation: Perspectives of patients, carers, and relatives
Emilia M Swietlik, Michaela Fay, Nicholas W Morrell
Pulmonary Circulation
|
October 29, 2011
Clinical demonstration of efficiency and reversibility of hypoxic pulmonary vasoconstriction in a patient presenting with unilateral incomplete bronchial occlusion
Syeda Jafri, Pasupathy Sivasothy, Francis Wells, et al.
Pulmonary Circulation
|
October 29, 2011
Expression of mutant BMPR-II in pulmonary endothelial cells promotes apoptosis and a release of factors that stimulate proliferation of pulmonary arterial smooth muscle cells
Xudong Yang, Lu Long, Paul N Reynolds, et al.
Biochemical Society Transactions
|
August 17, 2016
Regulation of the ALK1 ligands, BMP9 and BMP10
Wei Li, Richard M Salmon, He Jiang, et al.
Nature Reviews. Cardiology
|
August 14, 2019
Molecular genetic framework underlying pulmonary arterial hypertension
Laura Southgate, Rajiv D Machado, Stefan Gräf, et al.
Biochemical Society Transactions
|
May 26, 2019
Advances in the molecular regulation of endothelial BMP9 signalling complexes and implications for cardiovascular disease
Jennifer H Wood, Jingxu Guo, Nicholas W Morrell, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists
|
April 18, 2022
An emerging class of new therapeutics targeting TGF, Activin, and BMP ligands in pulmonary arterial hypertension
Paul D Upton, Benjamin J Dunmore, Wei Li, et al.
Circulation Research
|
April 26, 2019
Letter by Morrell et al Regarding Article, "Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension"
Nicholas W Morrell, Paul D Upton, Wei Li, et al.
Page
of 28
Search research articles
Search
Showing results (31-40 of 278) with videos related to
Sort By:
Page
of 28
Proceedings of the American Thoracic Society
|
October 30, 2010
Bone morphogenetic protein type II receptor mutations causing protein misfolding in heritable pulmonary arterial hypertension
Wei Li, Benjamin J Dunmore, Nicholas W Morrell
Paediatric Respiratory Reviews
|
November 22, 2005
New therapeutic agents for pulmonary vascular disease
Luke S G E Howard, Nicholas W Morrell
Pulmonary Circulation
|
February 16, 2024
Understanding what drives genetic study participation: Perspectives of patients, carers, and relatives
Emilia M Swietlik, Michaela Fay, Nicholas W Morrell
Pulmonary Circulation
|
October 29, 2011
Clinical demonstration of efficiency and reversibility of hypoxic pulmonary vasoconstriction in a patient presenting with unilateral incomplete bronchial occlusion
Syeda Jafri, Pasupathy Sivasothy, Francis Wells, et al.
Pulmonary Circulation
|
October 29, 2011
Expression of mutant BMPR-II in pulmonary endothelial cells promotes apoptosis and a release of factors that stimulate proliferation of pulmonary arterial smooth muscle cells
Xudong Yang, Lu Long, Paul N Reynolds, et al.
Biochemical Society Transactions
|
August 17, 2016
Regulation of the ALK1 ligands, BMP9 and BMP10
Wei Li, Richard M Salmon, He Jiang, et al.
Nature Reviews. Cardiology
|
August 14, 2019
Molecular genetic framework underlying pulmonary arterial hypertension
Laura Southgate, Rajiv D Machado, Stefan Gräf, et al.
Biochemical Society Transactions
|
May 26, 2019
Advances in the molecular regulation of endothelial BMP9 signalling complexes and implications for cardiovascular disease
Jennifer H Wood, Jingxu Guo, Nicholas W Morrell, et al.
Developmental Dynamics : an Official Publication of the American Association of Anatomists
|
April 18, 2022
An emerging class of new therapeutics targeting TGF, Activin, and BMP ligands in pulmonary arterial hypertension
Paul D Upton, Benjamin J Dunmore, Wei Li, et al.
Circulation Research
|
April 26, 2019
Letter by Morrell et al Regarding Article, "Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension"
Nicholas W Morrell, Paul D Upton, Wei Li, et al.
Page
of 28